Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Horowitz

Showing results (621-630 of 701) with videos related to

Pageof 71
Sort By:
Reproductive Sciences (Thousand Oaks, Calif.)|June 15, 2021
Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic NeoplasiaJessica D St Laurent, Lawrence H Lin, David M Owen, et al.
Diagnostics (Basel, Switzerland)|August 28, 2025
Diagnosis and Surgical Treatment of Hydatidiform MoleAntônio Braga, Marcela Chagas, Manisha Asrani, et al.
Gynecologic Oncology|February 16, 2012
Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapyNoah Rodriguez, J Alejandro Rauh-Hain, Melina Shoni, et al.
Cancer|July 25, 2014
Complications of pelvic radiation in patients treated for gynecologic malignanciesAkila N Viswanathan, Larissa J Lee, Jairam R Eswara, et al.
Gynecologic Oncology|February 20, 2014
Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysisRoberto Vargas, J Alejandro Rauh-Hain, Joel Clemmer, et al.
Diabetes Research and Clinical Practice|May 31, 2021
An analysis of Medtronic MiniMed 670G insulin pump use in clinical practice and the impact on glycemic control, quality of life, and complianceMaxwell E Horowitz, William A Kaye, Gary M Pepper, et al.
Clinics (Sao Paulo, Brazil)|March 3, 2025
Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factorsMarcio Barcellos, Antonio Braga, Matheus Machado Rech, et al.
Gynecologic Oncology|July 16, 2021
Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?Juliana Gomes Poli, Gabriela Paiva, Fernanda Freitas, et al.
Clinical Ovarian Cancer and Other Gynecologic Malignancies|August 12, 2011
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian CarcinomaNeil S Horowitz, Richard T Penson, Dan G Duda, et al.
Clinics (Sao Paulo, Brazil)|June 28, 2025
Response to commentary on "pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors"Marcio Barcellos, Antonio Braga, Matheus Machado Rech, et al.
Pageof 71

Showing results (621-630 of 701) with videos related to

Sort By:
Pageof 71
Reproductive Sciences (Thousand Oaks, Calif.)|June 15, 2021
Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic NeoplasiaJessica D St Laurent, Lawrence H Lin, David M Owen, et al.
Diagnostics (Basel, Switzerland)|August 28, 2025
Diagnosis and Surgical Treatment of Hydatidiform MoleAntônio Braga, Marcela Chagas, Manisha Asrani, et al.
Gynecologic Oncology|February 16, 2012
Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapyNoah Rodriguez, J Alejandro Rauh-Hain, Melina Shoni, et al.
Cancer|July 25, 2014
Complications of pelvic radiation in patients treated for gynecologic malignanciesAkila N Viswanathan, Larissa J Lee, Jairam R Eswara, et al.
Gynecologic Oncology|February 20, 2014
Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysisRoberto Vargas, J Alejandro Rauh-Hain, Joel Clemmer, et al.
Diabetes Research and Clinical Practice|May 31, 2021
An analysis of Medtronic MiniMed 670G insulin pump use in clinical practice and the impact on glycemic control, quality of life, and complianceMaxwell E Horowitz, William A Kaye, Gary M Pepper, et al.
Clinics (Sao Paulo, Brazil)|March 3, 2025
Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factorsMarcio Barcellos, Antonio Braga, Matheus Machado Rech, et al.
Gynecologic Oncology|July 16, 2021
Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?Juliana Gomes Poli, Gabriela Paiva, Fernanda Freitas, et al.
Clinical Ovarian Cancer and Other Gynecologic Malignancies|August 12, 2011
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian CarcinomaNeil S Horowitz, Richard T Penson, Dan G Duda, et al.
Clinics (Sao Paulo, Brazil)|June 28, 2025
Response to commentary on "pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors"Marcio Barcellos, Antonio Braga, Matheus Machado Rech, et al.
Pageof 71